This inventor holds 1 USPTO granted patent. Top assignee: Mcgill University. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Colin Crist: Innovator in Stem Cell Research
Introduction
Colin Crist is a notable inventor based in Montréal, Canada. He has made significant contributions to the field of stem cell research, particularly through his innovative patent related to the regulation of stem cell properties.
Latest Patents
Colin Crist holds a patent for an "Inhibitor of EIF2α dephosphorylation." This patent describes a compound of formula (I), which acts as an inhibitor of the dephosphorylation of phosphorylated elF2α. The phosphorylation of elF2α plays a crucial role in the quiescence and self-renewal properties of stem cells, including muscle stem cells. The compound can be utilized to expand stem cell populations and treat degenerative diseases that are influenced by the phosphorylation of elF2α.
Career Highlights
Colin Crist is affiliated with McGill University, where he conducts research and develops innovative solutions in the realm of stem cell biology. His work has the potential to impact the treatment of various degenerative diseases, showcasing his commitment to advancing medical science.
Collaborations
Colin collaborates with Jean-Philip Lumb, further enhancing the research efforts in their field. Their partnership exemplifies the importance of teamwork in scientific innovation.
Conclusion
Colin Crist's contributions to stem cell research through his patent demonstrate his innovative spirit and dedication to improving health outcomes. His work at McGill University continues to pave the way for advancements in regenerative medicine.